NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘drugs’

7 January 2015

NeoMed co-leads $19.7m Series D for drug developer Genkyotex

pills-1111307-m European venture capital firm NeoMed Management has led a CHF20m ($19.7m) financing round for Genkyotex, a company developing drugs to treat diseases of the kidney, liver, lung and skin.

5 December 2014

GSK abandons $3bn-plus plan to sell older drugs portfolio

pills-1111307-m Pharmaceutical giant GlaxoSmithKline has decided not to sell a portfolio of older drugs marketed in North America and Europe, despite strong interest from private equity firms and offers upwards of $3bn.

4 August 2014

KKR, Warburg Pincus among suitors for GSK, Sanofi drugs

pills Private equity firms are reportedly planning to buy older drugs from pharmaceutical groups GlaxoSmithKline and Sanofi and merge them.

28 July 2014

Sanofi’s $8.5bn mature drug portfolio draws private equity interest

green pills A trio of private equity majors are reportedly interested in French pharmaceutical company Sanofi’s $8.5bn portfolio of older, off-patent drugs.

21 July 2014

Blackstone-backed healthcare company Catalent targets up to $935m in New York IPO

medicals-962561-m Private equity giant Blackstone is set to retain its majority holding in healthcare and drug company Catalent when its floats on the New York Stock Exchange later this year.

17 July 2014

UrgentRX raises $17.5m to fund major marketing campaign

urgent Denver-based startup UrgentRX, which sells over-the-counter drugs in powdered form, has raised $17.5m in a Series C round.

23 June 2014

Luye Pharma’s private equity backers look to raise $761m via Hong Kong IPO

hong kong The private equity backers of Luye Pharma Group are reportedly looking to raise as much as HK$5.9bn ($761m) in the IPO of the Chinese drug maker.

30 May 2014

GSK looks to sell older drugs to buyout firms

meddd GlaxoSmithKline is reportedly looking to sell a range of its older drugs to private equity firms.

25 November 2013

BC Partners, Onex to bid for venture capital-backed Ikaria

biotech_lrg Private equity firms BC Partners, Onex Corp and American Securities are reportedly set to make second round bids for specialty drug business Ikaria.


Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015